Home/Filings/4/0001231977-12-000026
4//SEC Filing

Coissac Patrice 4

Accession 0001231977-12-000026

CIK 0000899866other

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 5:43 PM ET

Size

7.0 KB

Accession

0001231977-12-000026

Insider Transaction Report

Form 4
Period: 2012-02-03
Coissac Patrice
GM/President ALXN SAS Europe
Transactions
  • Exercise/Conversion

    Option to Purchase Common Stock

    2012-02-03+64,00064,000 total
    Exercise: $78.88From: 2012-05-03Exp: 2022-02-03Common Stock, par value $.0001 per share (64,000 underlying)
  • Exercise/Conversion

    Common Stock, par value $.0001 per share

    2012-02-03+8,00085,882 total
Footnotes (2)
  • [F1]Award of Restricted Stock Units pursuant to 2004 Incentive Plan. 50% vests on two year anniversary of grant date and 1/8 vests every 6 months thereafter.
  • [F2]1/16 vests every three months following grant date.

Issuer

ALEXION PHARMACEUTICALS INC

CIK 0000899866

Entity typeother

Related Parties

1
  • filerCIK 0001341212

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 5:43 PM ET
Size
7.0 KB